Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|13|6|478-491

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.13, Iss.6, 2013-12, pp. : 478-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 385-394

Bentham Science Publishers

Access to resources Recommend Favorite

Replicating herpes simplex virus vectors for cancer gene therapy

By Yeung S.N.   Tufaro F.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic: Herpes Simplex Virus Type 1-Based Amplicons Vectors (Guest Editor: Alberto L. Epstein)]

By  

Current Gene Therapy, Vol. 6, Iss. 3, 2006-06 ,pp. : 275-276

Bentham Science Publishers

Access to resources Recommend Favorite

Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery

By Gaston David C   Whitley Richard J   Parker Jacqueline N  

Future Virology, Vol. 6, Iss. 3, 2011-03 ,pp. : 321-340

Future Medicine

Access to resources Recommend Favorite

Herpes Simplex Virus Vectors for Gene Delivery to a Variety of Different Cell Types

By  

Current Gene Therapy, Vol. 2, Iss. 4, 2002-12 ,pp. : 415-426

Bentham Science Publishers

Access to resources Recommend Favorite